Leukemia

Case Series
Perianal Infections in Patients With Hematologic Malignancy: The Risk of Fournier’s Gangrene Leading to Mortality and Irreversible Organ Damage
09/14/2021
This article presents a case series of perianal infection progressing to Fournier’s gangrene (FG) in patients with hematologic malignancy to guide physicians.
This article presents a case series of perianal infection progressing to Fournier’s gangrene (FG) in patients with hematologic malignancy to guide physicians.
This article presents a case...
09/14/2021
Wounds
Research in Review
Prior Malignancies Do Not Affect CML Outcomes
11/02/2016
JCP Editors
Patients with chronic myeloid leukemia (CML) and a history of prior malignancies appear to have the same outcomes as patients with no prior malignancies, according to a study published in Cancer. ------ Related...
Patients with chronic myeloid leukemia (CML) and a history of prior malignancies appear to have the same outcomes as patients with no prior malignancies, according to a study published in Cancer. ------ Related...
...
11/02/2016
Journal of Clinical Pathways
Research in Review
Outcomes of Treating ALL With Inotuzumab Ozogamicin
06/14/2016
JCP Editors
A clinical trial assessing the use of inotuzumab ozogamicin in patients with acute lymphoblastic leukemia (ALL) has found that it may be a more effective treatment option than current standard practice. Inotuzumab...
A clinical trial assessing the use of inotuzumab ozogamicin in patients with acute lymphoblastic leukemia (ALL) has found that it may be a more effective treatment option than current standard practice. Inotuzumab...
A...
06/14/2016
Journal of Clinical Pathways
Strict Adherence to Ibrutinib Therapy Improves PFS for Chronic Lymphocytic Leukemia
05/05/2016
JCP Editors
Ibrutinib may improve progression-free survival (PFS) for patients with chronic lymphocytic leukemia (CLL) if the full dose is taken on schedule, according to results extracted from clinical trial data and presented...
Ibrutinib may improve progression-free survival (PFS) for patients with chronic lymphocytic leukemia (CLL) if the full dose is taken on schedule, according to results extracted from clinical trial data and presented...
...
05/05/2016
Journal of Clinical Pathways
Research in Review
High-Dose Treatment for Acute Lymphoblastic Leukemia Safe, Improves Survival
04/29/2016
JCP Editors
Initial results from a clinical trial have shown that high-dose methotrexate may be superior to standard, low-dose regimens without increasing toxicity for children and young adults with high-risk B-acute...
Initial results from a clinical trial have shown that high-dose methotrexate may be superior to standard, low-dose regimens without increasing toxicity for children and young adults with high-risk B-acute...
...
04/29/2016
Journal of Clinical Pathways
Research in Review
Imatinib Projected to Be Most Cost-Effective Option for CML
03/14/2016
JCP Editors
According to researchers, imatinib is projected to become the most cost-effective initial treatment strategy for patients with chronic myeloid leukemia in chronic phase (CML-CP) after its patent expires later this...
According to researchers, imatinib is projected to become the most cost-effective initial treatment strategy for patients with chronic myeloid leukemia in chronic phase (CML-CP) after its patent expires later this...
...
03/14/2016
Journal of Clinical Pathways
Research in Review
Costs for High-Risk Patients With ALL Increasing
02/25/2016
JCP Editors
Costs for high-risk pediatric and adolescent patients with acute lymphoblastic leukemia (ALL) may be higher than standard-risk patients with the disease, according to a recent study. While data regarding health care...
Costs for high-risk pediatric and adolescent patients with acute lymphoblastic leukemia (ALL) may be higher than standard-risk patients with the disease, according to a recent study. While data regarding health care...
Costs...
02/25/2016
Journal of Clinical Pathways
Research in Review
New Assay More Sensitive for Identifying CML Remission Likely to Relapse
02/10/2016
JCP Editors
A new personalized DNA-based digital polymerase chain reaction (dPCR) assay could help determine which patients with chronic myeloid leukemia (CML) are more likely to relapse while in molecular remission. Advances...
A new personalized DNA-based digital polymerase chain reaction (dPCR) assay could help determine which patients with chronic myeloid leukemia (CML) are more likely to relapse while in molecular remission. Advances...
A new...
02/10/2016
Journal of Clinical Pathways
Case Report and Brief Review
Hemicellulose Dressing for Skin Lesions Caused by Herpes Zoster in a Patient With Leukemia—An Alternative Dressing
01/01/2009
01/01/2009
Wounds

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use